(lp0
S'Amicus Therapeutics, Inc. : Ignore the noise and focus on the technicals USA Commerce Daily - 12 hours ago With all other things going on, Amicus Therapeutics, Inc.  has been on a run - rising 65.56 percent in just three months.'
p1
aS'Amicus Therapeutics, Inc.  And The Naked Truth Exposed In Its Technicals NY Stock News - 17 hours ago Amicus Therapeutics, Inc.  has created a compelling message for traders in the most recent trading. That message has grown stronger as the technical chart setup has developed into a more composite picture for the stock.'
p2
aS"Why Amicus Therapeutics, Inc. Jumped Higher Today Motley Fool - Mar 1, 2017 Amicus Therapeutics  ended the day up 17%, after the company's CEO John Crowley and his daughter Megan  were highlighted during President Donald Trump's address to Congress last night.The Unlikely Story Of How Amicus Therapeutics Came To Be - BenzingaAmicus Therapeutics, Inc.  Could Be The Force That Brings Change ... - Market Exclusive"
p3
aS"Today's Brokerage Rating: Amicus Therapeutics, Inc. , Cabot Oil &amp; Gas ... StockNewsJournal - 19 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business."
p4
aS'Looking at the Numbers for Amicus Therapeutics, Inc.  Baldwin Journal - 10 hours ago Amicus Therapeutics, Inc.  currently has a 6 month price index of 0.98425. The six month price index is simply measured by dividing the current share price by the share price six months ago.'
p5
aS"Occidental Petroleum Corporation , Amicus Therapeutics, Inc.  Stock ... The USA Commerce - Mar 27, 2017 Shares of Occidental Petroleum Corporation  dropped -0.33% to $62.83. During the trading on 03/24/2017, Company's stock ranged from $63.42 to $62.43. The relative strength index or RSI highlights overbought  and oversold (below&nbsp;..."
p6
aS"Amicus: Key Catalysts Approaching Seeking Alpha - Mar 24, 2017 Amicus Therapeutics  has done a solid job launching Galafold in Germany, and is looking to replicate the success in other countries in 2017.Amicus Therapeutics, Inc. : A Detailed Look at its Institutional Ownership - Post AnalystWhat's Acceptable Profitability For Biocept, Inc.  and Amicus ... - USA Commerce Daily"
p7
aS'Amicus Therapeutics Inc.  Soars 7.89% on February 27 Equities.com - Feb 27, 2017 Amicus Therapeutics Inc.  had a good day on the market for Monday February 27 as shares jumped 7.89% to close at $6.43.'
p8
aS"Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and ... Yahoo Finance - Mar 17, 2017 Amicus has had a number of investment firms, including JP Morgan Chase, confirming or raising their rating of the company from a &quot;hold&quot; to a &quot;buy&quot; during the early months of 2017, with consensus rating as &quot;outperform&quot;. The company specializes in the&nbsp;..."
p9
aS'Amicus Therapeutics Launches Galafold  for Treatment of Fabry ... GlobeNewswire  - Feb 27, 2017 CRANBURY, N.J., Feb. 27, 2017  -- Amicus Therapeutics , a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision medicine Galafold in the&nbsp;...Amicus Therapeutics  Launches Galafold in the UK - StreetInsider.com'
p10
a.